DG:NYSEDollar General Corporation Analysis
Data as of 2026-09-01 - not real-time
$131.25
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Dollar General Corporation trades at $131.25, with its moving averages tangled rather than clearly stacked — a neutral trend structure. Across the trailing 30 sessions it gained 6.5%. With RSI at 62.7 the momentum picture is approaching overbought, alongside a bullish MACD signal. The recent range runs from support at $117.51 up to resistance at $132.50.
On valuation the read is fair — an earnings multiple of 17.1, absent a reliable peer benchmark. Sell-side targets cluster 5.4% above the current quote. Revenue is growing at 5.2% on a 3.9% profit margin. The 1.86% dividend yield looks covered by current payout levels.
Risk scores 5 out of 10, which is moderate for this asset class. With 30-day volatility of 34.9%, a beta of 0.49 and a maximum drawdown of 34.9%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 5/10.
On valuation the read is fair — an earnings multiple of 17.1, absent a reliable peer benchmark. Sell-side targets cluster 5.4% above the current quote. Revenue is growing at 5.2% on a 3.9% profit margin. The 1.86% dividend yield looks covered by current payout levels.
Risk scores 5 out of 10, which is moderate for this asset class. With 30-day volatility of 34.9%, a beta of 0.49 and a maximum drawdown of 34.9%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 5/10.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 5/10
Key Factors
- Trading above the 200-day average of 125.68
- MACD momentum is positive
- 30-day price change of +6.5%
Medium Term
1–3 yearsPositive
Model confidence: 5/10
Key Factors
- Trading above the 200-day average of 125.68
- Analyst targets imply +5.4% versus the current price
- MACD momentum is positive
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- Analyst targets imply +5.4% versus the current price
- P/E ratio of 17.1
- Return on equity of 19.7%
Key Metrics & Analysis
Financial Health
Revenue Growth5.20%
Profit Margin3.90%
P/E Ratio17.1
ROE19.69%
ROA4.89%
Debt/Equity169.81
P/B Ratio3.1
Op. Cash Flow$3.3B
Free Cash Flow$1.7B
Technical Analysis
TrendNeutral
RSI62.7
Support$117.51
Resistance$132.50
MA 20$123.66
MA 50$121.94
MA 200$125.68
MACDBullish
VolumeIncreasing
Fear & Greed Index92.7
Valuation
Fair Value$60.94
Target Price$138.32
Upside/Downside5.39%
GradeFair
TypeBlend
Dividend Yield1.86%
Risk Assessment
Beta0.49
Volatility34.92%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.